发明名称 |
METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR |
摘要 |
The present invention relates generally to the use of gene mutations, whose presence or absence are useful for predicting a patient's response to treatment with an anti-proliferative agent, in particular a WEE1 inhibitor. The presence or absence of a mutation to the TP53 gene, can be used to predict response to treatment with a WEE1 inhibitor in a patient presenting with a cancerous condition. |
申请公布号 |
EP3148544(A1) |
申请公布日期 |
2017.04.05 |
申请号 |
EP20150800163 |
申请日期 |
2015.05.26 |
申请人 |
Merck Sharp & Dohme Corp. |
发明人 |
MARTON, Matthew J.;BENITA, Yair |
分类号 |
A61K31/519 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|